Downregulation of Gldc Attenuates Myocardial Ischemia Reperfusion Injury in Vitro by Modulating Akt and NF-κB Signalings

Overview

Journal Sci Rep

Specialty Science

Date 2025 Jan 2

PMID 39747134

Authors

Lian Shuang

Youle Su

Yue Zhang

Affiliations

Soon will be listed here.

Abstract

Myocardial ischemia/reperfusion injury (MIRI) is a serious clinical complication that is caused by reperfusion therapy following myocardial infarction (MI). Mitochondria-related genes (Mito-RGs) play important roles in multiple diseases. However, the role of mitochondria-related genes in MIRI remains largely unknown. The GSE67308 dataset from the GEO database was utilized to identify MIRI-related gene modules through WGCNA. Meanwhile, differential expression analysis was conducted to identify differentially expressed genes (DEGs) in the GSE61592 dataset. Next, candidate Mito-RGs related to MIRI were screened by Venn analysis. Thereafter, a myocardial hypoxia/reperfusion (H/R) H9C2 cell model and a mouse ischemia/reperfusion (I/R) model were established to verify the expression level of glycine decarboxylase (Gldc) in MIRI in vitro and in vivo. Based on data from the GEO database, Gldc levels were notably upregulated in murine MIRI samples, compared to the control group. RT-qPCR and western blot confirmed that Gldc levels were obviously elevated in the heart of I/R mice and H/R-exposed cardiomyocytes. Moreover, the deficiency of Gldc notably increased the viability and reduced the apoptosis and inflammatory responses in H9C2 cells exposed to H/R. Meanwhile, Gldc downregulation significantly reduced p-NF-κB p65, Bax and cleaved caspase 3 levels and elevated p-Akt and Bcl-2 levels in H9C2 cells exposed to H/R. The ROC curve analysis further demonstrated that Gldc gene exhibited good diagnostic value for MIRI. Collectively, Gldc deficiency could attenuate H/R injury in cardiomyocytes in vitro through activating Akt and inactivating NF-κB signalings. These data suggested that GLDC may serve as both a diagnostic and therapeutic target for MIRI.

References

Wang Y, Liu H, Sun N, Li J, Peng X, Jia Y . Irisin: A Promising Target for Ischemia-Reperfusion Injury Therapy. Oxid Med Cell Longev. 2021; 2021():5391706. PMC: 8570861. DOI: 10.1155/2021/5391706. View

Qin G, Lu P, Peng L, Jiang W . Ginsenoside Rb1 Inhibits Cardiomyocyte Autophagy via PI3K/Akt/mTOR Signaling Pathway and Reduces Myocardial Ischemia/Reperfusion Injury. Am J Chin Med. 2021; 49(8):1913-1927. DOI: 10.1142/S0192415X21500907. View

Li D, Gao S . The interplay between T lymphocytes and macrophages in myocardial ischemia/reperfusion injury. Mol Cell Biochem. 2023; 479(8):1925-1936. DOI: 10.1007/s11010-023-04822-z. View

Yan Y, Tian L, Jia Q, Han Y, Tian Y, Chen H . MiR-130a-3p regulates FUNDC1-mediated mitophagy by targeting GJA1 in myocardial ischemia/reperfusion injury. Cell Death Discov. 2023; 9(1):77. PMC: 9968299. DOI: 10.1038/s41420-023-01372-7. View

Yu D, Gong X, Zhang Y, Li Q, Zhang M . Tropisetron Preconditioning Decreases Myocardial Biomarkers in Patients Undergoing Heart Valve Replacement Surgery. Front Med (Lausanne). 2022; 9:690272. PMC: 9002259. DOI: 10.3389/fmed.2022.690272. View

Shu Q, She H, Chen X, Zhong L, Zhu J, Fang L . Identification and experimental validation of mitochondria-related genes biomarkers associated with immune infiltration for sepsis. Front Immunol. 2023; 14:1184126. PMC: 10203506. DOI: 10.3389/fimmu.2023.1184126. View

Su J, Li Y, Liu Q, Peng G, Qin C, Li Y . Identification of SSBP1 as a ferroptosis-related biomarker of glioblastoma based on a novel mitochondria-related gene risk model and in vitro experiments. J Transl Med. 2022; 20(1):440. PMC: 9524046. DOI: 10.1186/s12967-022-03657-4. View

Langfelder P, Horvath S . WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008; 9:559. PMC: 2631488. DOI: 10.1186/1471-2105-9-559. View

Sun Q, Ma H, Zhang J, You B, Gong X, Zhou X . A Self-Sustaining Antioxidant Strategy for Effective Treatment of Myocardial Infarction. Adv Sci (Weinh). 2022; 10(5):e2204999. PMC: 9929116. DOI: 10.1002/advs.202204999. View

10.

Li T, Zhang Z, Kolwicz Jr S, Abell L, Roe N, Kim M . Defective Branched-Chain Amino Acid Catabolism Disrupts Glucose Metabolism and Sensitizes the Heart to Ischemia-Reperfusion Injury. Cell Metab. 2017; 25(2):374-385. PMC: 5301464. DOI: 10.1016/j.cmet.2016.11.005. View

11.

Braunwald E, Pfeffer M . Ventricular enlargement and remodeling following acute myocardial infarction: mechanisms and management. Am J Cardiol. 1991; 68(14):1D-6D. DOI: 10.1016/0002-9149(91)90255-j. View

12.

Zhang D, Wu H, Liu D, Li Y, Zhou G . Research Progress on The Mechanism and Treatment of Inflammatory Response in Myocardial Ischemia-Reperfusion Injury. Heart Surg Forum. 2022; 25(3):E462-E468. DOI: 10.1532/hsf.4725. View

13.

Li X, Ma N, Xu J, Zhang Y, Yang P, Su X . Targeting Ferroptosis: Pathological Mechanism and Treatment of Ischemia-Reperfusion Injury. Oxid Med Cell Longev. 2021; 2021:1587922. PMC: 8568519. DOI: 10.1155/2021/1587922. View

14.

Hoffmann J, Fiser K, Weaver J, Dimmick I, Loeher M, Pircher H . High-throughput 13-parameter immunophenotyping identifies shifts in the circulating T-cell compartment following reperfusion in patients with acute myocardial infarction. PLoS One. 2012; 7(10):e47155. PMC: 3473067. DOI: 10.1371/journal.pone.0047155. View

15.

Yang C, Jin Y, Mei J, Hu D, Jiao X, Che H . Identification of icaritin derivative IC2 as an SCD-1 inhibitor with anti-breast cancer properties through induction of cell apoptosis. Cancer Cell Int. 2022; 22(1):202. PMC: 9153146. DOI: 10.1186/s12935-022-02621-y. View

16.

Zhuang H, Li Q, Zhang X, Ma X, Wang Z, Liu Y . Downregulation of glycine decarboxylase enhanced cofilin-mediated migration in hepatocellular carcinoma cells. Free Radic Biol Med. 2018; 120:1-12. DOI: 10.1016/j.freeradbiomed.2018.03.003. View

17.

Guo W, Mu K, Li W, Gao S, Wang L, Li X . Identification of mitochondria-related key gene and association with immune cells infiltration in intervertebral disc degeneration. Front Genet. 2023; 14:1135767. PMC: 10030706. DOI: 10.3389/fgene.2023.1135767. View

18.

Proctor P, Leesar M, Chatterjee A . Thrombolytic Therapy in the Current ERA: Myocardial Infarction and Beyond. Curr Pharm Des. 2017; 24(4):414-426. DOI: 10.2174/1381612824666171227211623. View

19.

Cheng Y, Cheng L, Gao X, Chen S, Wu P, Wang C . Covalent modification of Keap1 at Cys77 and Cys434 by pubescenoside a suppresses oxidative stress-induced NLRP3 inflammasome activation in myocardial ischemia-reperfusion injury. Theranostics. 2021; 11(2):861-877. PMC: 7738871. DOI: 10.7150/thno.48436. View

20.

Marin W, Marin D, Ao X, Liu Y . Mitochondria as a therapeutic target for cardiac ischemia‑reperfusion injury (Review). Int J Mol Med. 2021; 47(2):485-499. PMC: 7797474. DOI: 10.3892/ijmm.2020.4823. View